Latest Prostate-specific antigen Stories
Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.
Recent studies have suggested that PSA testing for prostate cancer is an unneeded medical screening process that often does more harm than good. However, a new report, published in the journal Cancer, states that eliminating the PSA test would be taking a big step backward
Prostate cancer is the second leading cause of cancer death in the male population. Screening for the disease is done through a PSA test, but professional organizations vary in their recommendations about who should — and who shouldn't — get it.
A new study from the Harvard School of Public Health (HSPH) found that men who are diagnosed with prostate cancer have a greater chance to die due to preventable conditions like heart disease, rather than from the cancer itself.
In a study reported by the New England Journal of Medicine, researchers tried to determine which course of action is more beneficial for men diagnosed with localized prostate cancer through the prostate-specific antigen (PSA) test: radical prostatectomy or observation without surgery?
- An imitative word; an onomatopoetic word.